POSTER SESSION V
Wednesday, March 2, 2011   —  9:30 AM - 12:00 Noon
Exhibit Hall


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




PATHOBIOLOGY



Poster#Title and AuthorsItinerary
Planner
207 High-Throughput Prostate Cancer Gland Segmentation and Classification from Digitized Needle Core Biopsies. (1700)
J Xu, R Sparks, A Janowcyzk, JE Tomaszewski, A Madabhushi - Rutgers University, Piscataway, NJ; The Hospital of the University of Pennsylvania, Philadelphia; IIT Bombay, Piscataway, NJ
Add
208 The sAC Antibody Profile as a Diagnostic Adjunct in the Assessment of Pigmented Lesions. (1678)
CM Magro, G Desman, J Zippin, NA Crowson, P Chadwick - Weill Cornell Medical College, New York, NY; Laboratory of Dermatopathology, New York, NY; Regional Medical Laboratory, Tulsa, OK
Add
209 Validation Study for Use of Digital Microscopy for Primary Diagnosis in General Pathology. (1691)
L Schoenfield, R Slaw, S Mackie, S Crisostomo, P Suydam, T Bauer - Cleveland Clinic, OH
Add
210 Furin Expression in Seminal Vesicle. Any Impact on Prostate Cancer Development? (1667)
Y Gong, C Torres, C Sell, A Bitto, J Fu, AJ Klein-Szanto, FU Garcia - Drexel University College of Medicine, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA
Add
211 Development of a Scoring System for PTEN Immunohistochemistry in Breast Cancer. (1657)
R Bakkar, D Urbauer, R Broaddus - MD Anderson Cancer Center, Houston, TX
Add
212 The Use of Infrared Spectral Histopathology and Cytopathology. (1675)
NV Laver, BL Bird, JM Schubert, M Miljkovic, K Bedrossian, M Diem - Tufts Medical Center, Boston, MA; Northeastern University, Boston, MA
Add
213 Immunohistochemical Characterization of Pancreatic Adenocarcinomas Arising in Association with Intraductal Papillary Mucinous Neoplasms. (1698)
AK Witkiewicz, J Brody, J Kline, CJ Yeo, P McCue, NV Adsay, RH Hruban - Thomas Jefferson University, Philadelphia, PA; Johns Hopkins University, Baltimore, MD; Emory University, Atlanta, GA
Add
214 Modeling Neurogenetic Disorders Via Induced Pluripotent Stem Cells . A Novel Alternative for Pathology. (1658)
Y Bao, AJ Huttner - Yale University School of Medicine, New Haven, CT
Add
215 Immunophenotypic Characterization of Epithelial-Stromal Interface Cells. (1655)
P Adegboyega - LSU Health Sciences Center, Shreveport
Add
216 Raman Molecular Imaging Differentiates Epithelioid Mesothelioma from Metastatic-to-Pleura Bronchogenic Adenocarcinoma. (1692)
AM Schreiner, JS Maier, AJ Drauch, S Paul - Weill Cornell Medical College, New York, NY; ChemImage Corporation, Pittsburgh, PA
Add
217 Whole Transcriptome Profiling of Pure Cell Populations Isolated from Minute Prostate Needle Core Biopsies. (1693)
J Sweet, N Stickle, C Virtanen, L Qi, S Done, T Brown, K Hersey, N Fleshner, N Winegarden - University Health Network, Toronto, ON, Canada; Mt.Sinai Hospital, Toronto, ON, Canada
Add
218 Esophageal Dysmotility: A Manifestation of IgG4-Related Sclerosing Disease. (1671)
KB Johnson - Duke University Medical Center, Durham, NC
Add
219 Neurotensin Receptor 1 (NTSR1) Expression in Inflammatory Bowel Diseases (IBD): Association with Mucosal Inflammation and Dysplasia/Neoplasia. (1668)
X Gui, S Liu, Z-H Gao - University of Calgary, AB, Canada
Add
220 Detection of KRAS Mutation and Loss of Heterozygosity (LOH) in Mucinous Nonneoplastic Cyst of the Pancreas. (1703)
B Zhu, SD Finkelstein, Z Chen, X Lin - Northwestern University, Chicago; RedPath Integrated Pathology, Inc, Pittsburgh
Add
221 Acid Increases P16 Methylation Via Activation of NADPH Oxidase NOX5-S in Barrett's Esophageal Adenocarcinoma Cells. (1665)
W Cao, J Hong, J Behar, LJ Wang, J Wands, RA DeLellis, M Resnick - Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence
Add
222 Dickkopf-1 (Dkk-1) Is a New Agonist of the Orphan Receptor Tyrosine Kinase Ror-2 in Intestinal Epithelia. (1685)
II Pacheco, J Kelly, RJ MacLeod - Kingston General Hospital and Queen's University, ON, Canada
Add
223 Neurotensin Receptor 1 (NTSR1) Is Preferentially Expressed in Glandular Element of Intestinal Tumors with Neuroendocrine Differentiation. (1669)
X Gui, Y Li, S Liu, Z-H Gao - University of Calgary, AB, Canada
Add
224 Circadian Dysregulation in Colorectal Cancer: Decreased Nuclear Translocation of Cryptochrome 2. (1696)
MA Valasek, RN Van Gelder, SM Dintzis - University of Washington Medical Center, Seattle
Add
225 Autophagic Vacuolization as a Mechanism for Proteinuria-Induced Proximal Tubulopathy in the PEXTKO Mouse. (1674)
DR LaFrance, G Rhodes, B Molitoris, DJ McCarthy, KJ McCarthy - LSU Health Sciences Center, Shreveport, LA; Indiana University Purdue University at Indianpolis
Add
226 Osteoactivin Expression in Normal Human Tissues, Prostatic Adenocarcinoma and Renal Cell Carcinoma, Clear Cell Type. (1695)
GK Uppal, Y Huang, X Zhang, FF Safadi, W Tang, J Khurana - Temple University Hospital, Philadelphia, PA
Add
227 Evaluation of PTEN and TMPRSS2-ERG Abnormalities in Prostate Cancer by FISH and Immunohistochemistry To Address Intra- and Inter-Tissue Heterogeneity and Disease Progression. (1672)
AM Joshua, A Evans, J Squire, M Yoshimoto, O Ludkovski, S-H Tan, A Dobi, B Furusato, G Petrovics, S Srivastava, IA Sesterhenn - University of Toronto, ON, Canada; Toronto General Hospital, ON, Canada; Queens University, Kingston, ON, Canada; USUHS, Rockville, MD; Armed Forces Institute of Pathology, Washington, DC
Add
228 Carcinogen-Induced Breast Cancer Prevention by Ingestion of Stearate. (1670)
RW Hardy, E Toline, LM Evans, R Desmond, A Ibrahim-Hashim, GP Siegal - University of Alabama at Birmingham
Add
229 Progesterone Induces ERK 1/2 Activation and AP-1 DNA Binding Activity through a Mechanisms Involving Src Kinase and EGFR Transactivation in MCF-7 Breast Cancer Cell. (1663)
F Candanedo Gonzalez, P Cotes Reynosa, A Soto Guzman, M Guaderrama, T Robledo, E Perez Salazar - CINVESTAV-IPN, Mexico City, DF, Mexico
Add
230 RAS Mutational Analysis in 9334 Solid and Hematopoietic Malignancies. (1677)
D Ma, R Luthra, SS Chen, CC Yin, RL Sargent, KP Patel, J Medeiros, Z Zuo - The U of Texas M. D. Anderson Cancer Center, Houston
Add
231 Targeted Disruption of the CSF-1 Gene Leads to Osteopetrosis and Osteoblast Defects . (1654)
S Abboud Werner, D Horn, K Woodruff, R Fajardo, M Harris, S Harris - University of Texas Health Science Center, San Antonio
Add
232 BK Virus-Associated Immune-Mediated Tubulointerstitial Nephritis. Clinicopathologic Characterization. (1701)
J Xu, A Abdullatif, G Towns, L Gaber, R Barrios, L Truong - Changhai Hospital, Shanghai, China; Methodist Hospital, Houston, TX
Add
233 Merkel Cell Polyomavirus Detection in Extrapulmonary Small Cell Carcinoma. (1676)
JA Lefferts, KC Hourdequin, WA Hitzelberger, LJ Tafe, JM Pipas, MS Ernstoff, GJ Tsongalis - Dartmouth-Hitchcock Medical Center and Dartmouth Medical School, Lebanon, NH
Add
234 Ploidy and Gender in Cancer Survival. (1687)
I Petersen, S Schulze - Jena University Hospital, Jena, Germany
Add
235 Physiologic Replication of Human Disease with Murine Experimental Autoimmune Thyroiditis. (1704)
MI Zulfiqar, S Kari, J Flynn, D Snower, Y-C Kong - St John Hospital, Detroit, MI; Wayne State University, Detroit, MI; Providence Hospital, Detroit, MI
Add
236 Do Inflammatory Myofibroblastic Tumors (IMT) and IgG4 Related Lymphoplasmacytic Sclerosing Lesions (IgG4-RLSL) Have a Similar Pathogenesis? (1661)
SJ Bokhari, JF Silverman, A Mohanty - Allegheny General Hospital, Pittsburgh, PA
Add
237 Elevated Interstitial Pressure Enhances Hypoxia-Induced VEGF Expression Via HIF-1 in Daoy Medulloblastoma Cells. (1702)
H Zhong, R Wang, JW Simons - New York University, NY; Emory University, Atlanta
Add
238 Anatomic Study of the Renal Sympathetic Nervous System. (1656)
DS Atherton, FO Mendelsohn - Princeton Medical Center, Birmingham, AL
Add
239 Hypoxia-Related Protein Expression and Its Clinicopathologic Implication in Carcinoma of Unknown Primary. (1673)
JS Koo, H Kim - Yonsei University Health System, Seoul, Korea; Seoul National University Bundang Hospital, Seongnam, Korea
Add
240 FoxJ1 (Ciliogenic Transcription Factor) Expression in a Variety of Tumors. (1682)
D Nonaka - The Christie NHS Foundation Trust, Manchester, United Kingdom
Add
241 Susac's Syndrome: An Organ Specific Autoimmune Endotheliopathy Syndrome Associated with Antiendothelial Cell Antibodies. (1680)
CM Magro, JC Poe, M Lubow, JO Susac - Weill Cornell Medical College, New York, NY; Duke University Medical Center, Durham, NC; Ohio State University, Columbus; Neurology and Neurosurgery Associates, Winter Haven, FL
Add
242 Role of Meis1 in the Transcription of Mitochondrial Genes. (1694)
M Tomoeda, Y-F Jin, M Yuki, C Kubo, H Yoshizawa, Y Nishizawa, Y Tomita - Kobe International College, Hyogo, Japan; Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan
Add
243 Degos Disease: A C5B-9 and Interferon Alpha Mediated Small Vessel Injury Syndrome. (1679)
CM Magro, JC Poe, MK Crow, L Shapiro, G Nuovo, YJ Crow, C Kim - Weill Cornell Medical College, New York, NY; Duke University Medical Center, Durham, NC; Hospital for Special Surgery, New York, NY; Albany Medical College, New York, NY; Ohio State University, Columbus; University of Manchester, United Kingdom; New York University, NY
Add
244 The Roles of BDNF and SDF-1 Expression Levels and Polymorphisms in the Development of Intraventricular Hemorrhage in the Premature Infant Population. (1699)
Y Wu, S Canosa, Q Li, V Glinskii, I Buhimuschi, J Madri - Yale University School of Medicine, New Haven
Add
245 Perineural Invasion or Neurogenesis? (1664)
AM Cano-Valdez, N Cruz-Viruel, H Dominguez-Malagon - Instituto Nacional de Cancerologia, Mexico City, Mexico; Hospital Juarez de Mexico, Mexico City, Mexico
Add
246 Detection of EGFR Mutations and Exon 19 Deletions Using Primer Extension and Fragment Analysis in a Single Reaction. (1683)
E Olsen, J Mestas, W Grody, J Deignan - University of California, Los Angeles
Add